Cover Image

Adult Acute Lymphoblastic Leukemia: 2025 Update on Diagnosis, Therapy, and Monitoring

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Hagop Kantarjian, Elias Jabbour
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	American Journal of Hematology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring
by: Elias Jabbour, et al.
Published: (2024)

The Care and Cure of the Leukemias in 2026
by: Hagop Kantarjian, et al.
Published: (2026)

Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk‐Stratification, and Management
by: Shai Shimony, et al.
Published: (2025)

Chronic Lymphocytic Leukemia: 2025 Update on the Epidemiology, Pathogenesis, Diagnosis, and Therapy
by: Michael Hallek
Published: (2025)

Outcomes and Patterns of Relapse of NPM1 Mutated Acute Myeloid Leukemia Treated With Venetoclax Based Therapies
by: Wei‐Ying Jen, et al.
Published: (2025)

Patients First: Navigating Asparaginase‐Based Treatment in Young Adults With Acute Lymphoblastic Leukemia
by: Ryan D. Cassaday, et al.
Published: (2026)

Allogeneic Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults With Acute Lymphoblastic Leukemia—A Retrospective, Dual‐Center Study
by: Oren Pasvolsky, et al.
Published: (2025)

Clinico‐Genomic Interrogation of Secondary‐Type Acute Myeloid Leukemia: Response and Outcomes to Contemporary Therapies
by: Jayastu Senapati, et al.
Published: (2025)

Outcomes of Patients With Treated Secondary Acute Myeloid Leukemia: A High‐Risk Subtype That Warrants an Independent Prognostic Designation
by: Jayastu Senapati, et al.
Published: (2024)

Optimizing Asparaginase Treatment for Adolescent and Young Adult ( AYA ) Patients With Acute Lymphoblastic Leukemia: US Consensus Panel Recommendations
by: Ibrahim Aldoss, et al.
Published: (2025)

A Phase 2 Trial of CPX‐351 Combined With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia
by: Tapan M. Kadia, et al.
Published: (2025)

Venetoclax in Combination With Pediatric‐Inspired Chemotherapy in Adults With Newly Diagnosed Acute Lymphoblastic Leukemia: Results of a Phase I Trial
by: Yannis K. Valtis, et al.
Published: (2025)

Correction to “Analysis of 60 Patients with Relapsed or Refractory T‐cell Acute Lymphoblastic Leukemia and T‐cell Lymphoblastic Lymphoma Treated with CD7 ‐targeted Chimeric Antigen Receptor‐T Cell Therapy”
Published: (2024)

Outpatient Brexucabtagene Autoleucel in B‐Cell Acute Lymphoblastic Leukemia and Mantle Cell Lymphoma
by: Tamer Othman, et al.
Published: (2025)

Tandem CD19/CD22 CAR T‐Cell Therapy as First‐Line Treatment for Adult Patients With High‐Risk Philadelphia Chromosome Negative B‐Cell Acute Lymphoblastic Leukemia
by: Mengyun Li, et al.
Published: (2025)

Cladribine With Low‐Dose Cytarabine and Venetoclax Alternating With Azacitidine and Venetoclax for Newly Diagnosed Acute Myeloid Leukemia
by: Tapan M. Kadia, et al.
Published: (2026)

Therapeutic Advances and Future of Therapy in Acute Myeloid Leukemia
by: Farhad Ravandi
Published: (2025)

The Role of Allogeneic Hematopoietic Cell Transplantation in the Management of Philadelphia Chromosome‐Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors
by: Ivan Pasic, et al.
Published: (2026)

Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study From the Société Francophone de Greffe de Moelle et Thérapie Cellulaire (SFGM‐TC)
by: Yves Chalandon, et al.
Published: (2025)

Impact of Cytogenetic Response to Therapy on Long‐Term Survival in Acute Myeloid Leukemia
by: John Hanna, et al.
Published: (2025)

Characteristics and outcomes of patients with relapsed Philadelphia chromosome‐positive acute lymphoblastic leukemia after failure of a frontline ponatinib‐containing therapy
by: Nicholas J. Short, et al.
Published: (2024)

Mixed‐Phenotype Acute Leukemia With Mutated TP53 : Genetic Landscape, Therapeutic Response, and Outcomes
by: Wei J. Wang, et al.
Published: (2025)

A phase 2 trial of mini‐hyper‐CVD, blinatumomab, and ponatinib in Philadelphia positive acute lymphoblastic leukemia
by: Wei‐Ying Jen, et al.
Published: (2024)

DIA Regimen Versus IA Regimen for Induction Therapy in Younger Adults With Acute Myeloid Leukemia: A Multicenter Open‐Label Randomized Controlled Trial
by: Xiwen Tong, et al.
Published: (2025)

Classic Hairy Cell Leukemia With MAP2K1 Mutation: Diagnosis and Targeted Therapy
by: Andrea Duminuco, et al.
Published: (2025)

Long‐Term Outcomes of Stem Cell Transplant in Older Patients With Acute Myeloid Leukemia Treated With Venetoclax‐Based Therapies
by: Keith W. Pratz, et al.
Published: (2026)

BCR::ABL1‐Positive Acute Myeloid Leukemia
by: Alban Canali, et al.
Published: (2025)

Acute Megakaryoblastic Leukemia Masquerading as a Germ Cell Tumor
by: Lindsay M. Olson, et al.
Published: (2025)

Prospective Pharmacokinetic Evaluation of Venetoclax in AML Supports Re‐Evaluation of Recommended Dose Adjustments With Azole Antifungals
by: Jitesh D. Kawedia, et al.
Published: (2025)

Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid Leukemia
by: Somedeb Ball, et al.
Published: (2026)

Predictors of Relapse and Post‐Relapse Outcomes After Frontline Blinatumomab in Philadelphia Chromosome‐Negative B‐ ALL
by: Sankalp Arora, et al.
Published: (2026)

Hypomethylating Therapy With or Without Eltrombopag in Elderly Patients With Acute Myeloid Leukemia: Results From the Randomized, Placebo‐Controlled Phase 2 DELTA Trial
by: Katja Sockel, et al.
Published: (2025)

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): 2025 Update on Diagnosis, Pathophysiology, Risk Assessment, and Management
by: Shai Shimony, et al.
Published: (2025)

Targetable genetic abnormalities in patients with acute myeloblastic leukemia across age groups
by: Alex Bataller, et al.
Published: (2024)

Acute Leukemias of Ambiguous Lineage With MDS‐Associated Mutations Show Similar Prognosis Compared to Acute Myeloid Leukemia With MDS‐Associated Mutations: A Study From the Bone Marrow Pathology Group
by: Timothy J. Kirtek, et al.
Published: (2024)

Clinical and Prognostic Significance of Additional Chromosomal Abnormalities at Diagnosis of Chronic Myeloid Leukemia
by: Jiří Mayer, et al.
Published: (2025)

Mycosis Fungoides, Sézary Syndrome, and Cutaneous B‐Cell Lymphomas: 2025 Update on Diagnosis, Risk‐Stratification, and Management
by: Alexandra C. Hristov, et al.
Published: (2025)

Comparison of Frontline Therapies in Older Adults Age ≥ 80 Years With Chronic Lymphocytic Leukemia (CLL): A Mayo Clinic and Danish Nation‐Wide Study
by: Mazie Tsang, et al.
Published: (2025)

Marginal Zone Lymphoma: 2026 Update on Diagnosis and Management
by: Wan Danial Noor, et al.
Published: (2026)

Torque Teno Virus Drives Atypical Acute Promyelocytic Leukemia as a Novel Molecular Subtype
by: Xiaosu Zhou, et al.
Published: (2026)